Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
Andreas Puschmann
Parkinsonism & Related Disorders (2013) Vol. 19, Iss. 4, pp. 407-415
Open Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

Parkinson's disease
Lorraine V. Kalia, Anthony E. Lang
The Lancet (2015) Vol. 386, Iss. 9996, pp. 896-912
Closed Access | Times Cited: 4810
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Chunyan Guo, Li Sun, Xueping Chen, et al.
PubMed (2013) Vol. 8, Iss. 21, pp. 2003-14
Closed Access | Times Cited: 1102
Oxidative stress and Parkinson’s disease
Javier Blesa, Inés Trigo‐Damas, Ana Quiroga‐Varela, et al.
Frontiers in Neuroanatomy (2015) Vol. 9
Open Access | Times Cited: 774
Parkinson’s disease: animal models and dopaminergic cell vulnerability
Javier Blesa, Serge Przedborski
Frontiers in Neuroanatomy (2014) Vol. 8
Open Access | Times Cited: 430
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Surabhi Mehra, Shruti Sahay, Samir K. Maji
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2019) Vol. 1867, Iss. 10, pp. 890-908
Closed Access | Times Cited: 357
SOD2 in mitochondrial dysfunction and neurodegeneration
James M. Flynn, Simon Melov
Free Radical Biology and Medicine (2013) Vol. 62, pp. 4-12
Open Access | Times Cited: 311
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review
Meike Kasten, Corinna Hartmann, Jennie Hampf, et al.
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 730-741
Closed Access | Times Cited: 267
PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson’s Disease Pathobiology?
Dominika Truban, Xu Hou, Thomas R. Caulfield, et al.
Journal of Parkinson s Disease (2016) Vol. 7, Iss. 1, pp. 13-29
Open Access | Times Cited: 214
Autosomal dominant Parkinson's disease caused by SNCA duplications
Takuya Konno, Owen A. Ross, Andreas Puschmann, et al.
Parkinsonism & Related Disorders (2015) Vol. 22, pp. S1-S6
Open Access | Times Cited: 182
Identification of novel genetic causes of Rett syndrome-likephenotypes
Fátima Lopes, Mafalda Barbosa, Adam Ameur, et al.
Journal of Medical Genetics (2016) Vol. 53, Iss. 3, pp. 190-199
Open Access | Times Cited: 175
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
Yuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Brain (2020) Vol. 143, Iss. 7, pp. 2220-2234
Open Access | Times Cited: 139
Autophagy, aging, and age-related neurodegeneration
Jennifer E. Palmer, Niall Wilson, Sung Min Son, et al.
Neuron (2024)
Open Access | Times Cited: 20
Targeting mitophagy in neurodegenerative diseases
Odetta Antico, Paul Thompson, Nicholas T. Hertz, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 6
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Simone B. Larsen, Zoé Hanss, Rejko Krüger
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 21-37
Open Access | Times Cited: 159
Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
Mohammed Akbar, Musthafa Mohamed Essa, Ghazi Daradkeh, et al.
Brain Research (2016) Vol. 1637, pp. 34-55
Open Access | Times Cited: 154
Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease
Nikhil Panicker, Hariharan Saminathan, Huajun Jin, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 27, pp. 10058-10077
Open Access | Times Cited: 147
Glucocerebrosidase is shaking up the synucleinopathies
Marina Siebert, Ellen Sidransky, Wendy Westbroek
Brain (2014) Vol. 137, Iss. 5, pp. 1304-1322
Open Access | Times Cited: 145
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
Freja Herborg, Tina Skjørringe, Saiqa Yasmeen, et al.
Journal of Clinical Investigation (2014) Vol. 124, Iss. 7, pp. 3107-3120
Open Access | Times Cited: 143
The Expanding Spectrum of Neurological Phenotypes in Children With ATP1A3 Mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and Beyond
Matthew Sweney, Tara Newcomb, Kathryn J. Swoboda
Pediatric Neurology (2014) Vol. 52, Iss. 1, pp. 56-64
Open Access | Times Cited: 139
Single-Cell RNA-Seq of Mouse Dopaminergic Neurons Informs Candidate Gene Selection for Sporadic Parkinson Disease
Paul W. Hook, Sarah A. McClymont, Gabrielle H. Cannon, et al.
The American Journal of Human Genetics (2018) Vol. 102, Iss. 3, pp. 427-446
Open Access | Times Cited: 135
Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity
Agne Kazlauskaite, Van Kelly, Clare Johnson, et al.
Open Biology (2014) Vol. 4, Iss. 3, pp. 130213-130213
Open Access | Times Cited: 132
Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
Andreas Puschmann, Fabienne C. Fiesel, Thomas R. Caulfield, et al.
Brain (2016) Vol. 140, Iss. 1, pp. 98-117
Open Access | Times Cited: 132
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Ho‐Su Lee, Evy Lobbestael, Séverine Vermeire, et al.
Gut (2020), pp. gutjnl-322429
Open Access | Times Cited: 125
Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2017) Vol. 43, pp. 295-310
Closed Access | Times Cited: 120
Page 1 - Next Page

Scroll to top